The "U11/U12 snRNP 20K" refers to a component of the minor spliceosome, a complex involved in the splicing of a subset of pre-messenger RNA (pre-mRNA) molecules in eukaryotic cells. Specifically, it is a part of the U11/U12 small nuclear ribonucleoproteins (snRNPs), which play a crucial role in the recognition and removal of introns from pre-mRNA in the process known as minor spliceosome-mediated splicing.The "20K" in its name likely refers to the molecular weight (approximately 20 kilodaltons) of a protein component within this complex. Proteins within the U11/U12 snRNPs, like this 20K protein, are essential for the assembly, stability, and function of these snRNPs. They interact with RNA and other protein components to form a functional splicing complex.
The minor spliceosome, which includes U11, U12, U4atac, U5, and U6atac snRNPs, is responsible for the removal of a distinct class of introns, known as U12-type introns, from pre-mRNA. These introns are less common than the major class of introns (U2-type) but are highly conserved in eukaryotic organisms, indicating their importance in gene expression and regulation.The U11/U12 snRNP 20K protein contributes to the precise recognition and binding of the spliceosome to the specific splice sites on the pre-mRNA. This ensures accurate and efficient splicing, a process vital for the generation of mature and functional mRNA molecules, which are later translated into proteins.Understanding the function of U11/U12 snRNP 20K and the minor spliceosome is important not only for basic biological research but also for medical science, as aberrations in splicing can lead to various diseases, including cancer and genetic disorders. The study of these components can provide insights into the mechanisms of gene regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine, by affecting endosomal acidification, might indirectly impact cellular processes involving U11/U12 snRNP 20K. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide, a topoisomerase inhibitor, might affect RNA processing and indirectly influence U11/U12 snRNP 20K activity. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin, another topoisomerase inhibitor, could have indirect effects on U11/U12 snRNP 20K in RNA splicing. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D, by inhibiting RNA synthesis, might indirectly affect spliceosome-related proteins like U11/U12 snRNP 20K. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
DRB affects RNA polymerase II, potentially influencing RNA processing and U11/U12 snRNP 20K function. | ||||||
Harringtonin | 26833-85-2 | sc-204771 sc-204771A sc-204771B sc-204771C sc-204771D | 5 mg 10 mg 25 mg 50 mg 100 mg | $250.00 $367.00 $548.00 $730.00 $980.00 | 30 | |
Homoharringtonine, known to impact protein synthesis, might indirectly affect processes involving U11/U12 snRNP 20K. | ||||||